AstraZeneca Sues Mylan Over Entocort ANDA

Law360, New York (July 24, 2008, 12:00 AM EDT) -- AstraZeneca LP has sued Mylan Pharmaceuticals Inc. in an effort to prevent it from selling a generic version of Entocort EC, a drug used to treat Crohn's disease.

According to the complaint, filed Tuesday in the U.S. District Court for the District of Delaware, Mylan sent AstraZeneca a letter on June 9 saying that it had filed an abbreviated new drug application with the Food and Drug Administration to make generic Entocort.

AstraZeneca said that the proposed generic would infringe two of its patents. Mylan said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.